TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35830423

Group type: EXPERIMENTAL
Intervention: ZeroPhobia: Arachnophobia, a 6‐week Augmented Reality Exposure Therapy smartphone self‐help application
Number of subjects: 112

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 112
Study: 34167313

Group type: EXPERIMENTAL
Intervention: Sacrospinous hysteropexy
Number of subjects: 0
Study: 35012962

Group type: EXPERIMENTAL
Intervention: Plitidepsin 1.5 mg once daily for 3 days
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Plitidepsin 2.0 mg once daily for 3 days
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Plitidepsin 2.5 mg once daily for 3 days
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Plitidepsin (all doses)
Number of subjects: 46
Study: 32295593

Group type: EXPERIMENTAL
Intervention: Indacaterol/glycopyrronium/mometasone furoate (IND/GLY/MF) high-dose ICS (160 μg mometasone furoate)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Indacaterol/glycopyrronium/mometasone furoate (IND/GLY/MF) medium-dose ICS (80 μg mometasone furoate)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Salmeterol/fluticasone propionate (SFC) high-dose ICS (50/500 μg)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Indacaterol/glycopyrronium/mometasone furoate (IND/GLY/MF) high-dose ICS
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Indacaterol/glycopyrronium/mometasone furoate (IND/GLY/MF) medium-dose ICS
Number of subjects: 116
Study: 34818300

Group type: EXPERIMENTAL
Intervention: Early mobilization using a 4-step protocol
Number of subjects: 0
Study: 32870122

Group type: EXPERIMENTAL
Intervention: Extended release naltrexone (XR‐NTX)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 308
Study: 33147123

Group type: EXPERIMENTAL
Intervention: Inoculated with mycelial plugs from 5-day-old PDA colonies of Lasiodiplodia theobromae
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sterile PDA plugs (negative control)
Number of subjects: 15
Study: 33253691

Group type: EXPERIMENTAL
Intervention: Stimulation of a foot-related region in the anterior precuneus
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stimulation of a control region in the middle intraparietal sulcus (mIPS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 0
Study: 32239659

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 17160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17160
Study: 35952370

Group type: EXPERIMENTAL
Intervention: Grading of shoulder bursitis by fellowship trained musculoskeletal radiologists
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Years of experience of radiologists
Number of subjects: 70
Study: 33515069

Group type: EXPERIMENTAL
Intervention: Gluten-free diet (GFD) adherence in childhood
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Normalization of celiac serology in childhood
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Follow-up visits in childhood
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Serology testing in adulthood
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Normalization of serology in adulthood
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Attendance at gastroenterology clinic in adulthood
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Predictors of negative serology after age 18
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: CD-related complications
Number of subjects: 441
Study: 33206761

Group type: EXPERIMENTAL
Intervention: Continuous suprascapular nerve block (C‐SSNB)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Single-shot interscalene brachial plexus block (S‐ISNB)
Number of subjects: 118
Study: 35556169

Group type: EXPERIMENTAL
Intervention: Non-textbook outcome (non-TO) group
Number of subjects: 613

Group type: EXPERIMENTAL
Intervention: Nomograms based on non-TO
Number of subjects: 613

Group type: EXPERIMENTAL
Intervention: Nomogram score
Number of subjects: 613
Study: 34469767

Group type: EXPERIMENTAL
Intervention: Quadpill treatment (irbesartan 37.5 mg, amlodipine 1.25 mg, indapamide 0.625 mg, bisoprolol 2.5 mg)
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: Quadpill treatment
Number of subjects: 591

Group type: COMPARATOR
Intervention: Standard dose monotherapy (irbesartan 150 mg)
Number of subjects: 591

Group type: COMPARATOR
Intervention: Standard dose monotherapy
Number of subjects: 591
Study: 35671123

Group type: EXPERIMENTAL
Intervention: Prednisolone treatment
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 92
Study: 32362238

Group type: EXPERIMENTAL
Intervention: High-intensity intervention (Motivational interviewing, dietary advice on prescription, grocery store lecture, website, weekly e-mails)
Number of subjects: 289

Group type: COMPARATOR
Intervention: Low-intensity intervention (cookbooks and dietary lectures)
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: High-intensity group
Number of subjects: 289
Study: 35532889

Group type: EXPERIMENTAL
Intervention: 200 mg testosterone enanthate weekly (n=24)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (n=26)
Number of subjects: 50
Study: 33545945

Group type: EXPERIMENTAL
Intervention: Pestle needle therapy applied to acupoints (bilateral Shao ze, bilateral Ru gen, Dan zhong, 8 array acupoints of Shen dao) once a day for 5 days
Number of subjects: 128

Group type: COMPARATOR
Intervention: Routine nursing care of milk deficiency
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Pestle needle therapy
Number of subjects: 128
Study: 34563412

Group type: EXPERIMENTAL
Intervention: Neonatal circumcision + antibiotic prophylaxis (CATB)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Antibiotic prophylaxis alone (ATB)
Number of subjects: 91
Study: 32278783

Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 5898

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5898
Study: 33804374

Group type: EXPERIMENTAL
Intervention: Walking backward on a treadmill for 30 min, three times a week for four weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Traditional physical therapy for 30 min, three times a week for four weeks
Number of subjects: 16
Study: 36288583

Group type: EXPERIMENTAL
Intervention: US-guided Erector Spinae Block (ESB) with 25 mg bupivacaine 0.5% plus 8 mg dexamethasone (10 mL volume)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: US-guided Thoracic Paravertebral Block (PVB) with 25 mg bupivacaine 0.5% plus 8 mg dexamethasone (10 mL volume)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 90
Study: 33465277

Group type: EXPERIMENTAL
Intervention: PF-06372865 (25 mg twice daily for 14 days after titration for 7 days)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: PF-06372865 (42.5 mg twice daily for 14 days after titration for 7 days)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: PF-06372865
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 32533797

Group type: EXPERIMENTAL
Intervention: Web‐Push survey protocol
Number of subjects: 14709

Group type: COMPARATOR
Intervention: Standard mailed paper and pencil protocol
Number of subjects: 14709
Study: 35436355

Group type: EXPERIMENTAL
Intervention: High dose melatonin (5.0 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Low dose melatonin (0.3 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 33566065

Group type: EXPERIMENTAL
Intervention: Psilocybin-assisted therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32739044

Group type: EXPERIMENTAL
Intervention: Automated ventilation (adaptive support ventilation)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Conventional ventilation
Number of subjects: 220
Study: 35353163

Group type: EXPERIMENTAL
Intervention: Vaginal estradiol (10-μg)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Moisturizer
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study: 34483029

Group type: EXPERIMENTAL
Intervention: Ivermectin 24 mg
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Ivermectin 12 mg
Number of subjects: 157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Ivermectin 24 mg and 12 mg
Number of subjects: 157
Study: 36328190

Group type: EXPERIMENTAL
Intervention: Echinacea angustifolia 6cH and Avena sativa 6cH
Number of subjects: 18
Study: 32508080

Group type: EXPERIMENTAL
Intervention: Audiovisual (AV) task with mouth movements
Number of subjects: 0

Group type: COMPARATOR
Intervention: Auditory-only trials with static picture of a speaker
Number of subjects: 0
Study: 35599913

Group type: EXPERIMENTAL
Intervention: Greek yogurt (GY), 3 servings/day, 115 kcal, 17 g protein, 11.5 g carbohydrates
Number of subjects: 13

Group type: COMPARATOR
Intervention: Isoenergetic carbohydrate control (CHO), 3 servings/day, 115 kcal, 0.04 g protein, 28.6 g carbohydrates
Number of subjects: 13
Study: 34599919

Group type: EXPERIMENTAL
Intervention: PTSD+ (n=28)
Number of subjects: 89
Study: 34454821

Group type: EXPERIMENTAL
Intervention: Postoperative Atrial Fibrillation (POAF) within seven days after cardiac surgery
Number of subjects: 910

Group type: COMPARATOR
Intervention: No POAF
Number of subjects: 910
Study: 33864466

Group type: EXPERIMENTAL
Intervention: Healthy Lifestyles (HL) intervention, a 6 month multilevel intervention including educational workshop, self-monitoring, feedback, raffle incentive, social support, and center director coaching.
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Implementation of HL intervention components.
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Self-monitoring component of HL intervention.
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Raffle and social support components of HL intervention.
Number of subjects: 250
Study: 34870791

Group type: EXPERIMENTAL
Intervention: Gastropexy
Number of subjects: 200

Group type: COMPARATOR
Intervention: LSG without gastropexy
Number of subjects: 200
Study: 32330277

Group type: EXPERIMENTAL
Intervention: High-dosage CQ (600 mg CQ twice daily for 10 days)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Low-dosage CQ (450 mg twice daily on day 1 and once daily for 4 days)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: High-dosage CQ
Number of subjects: 81

Group type: COMPARATOR
Intervention: Low-dosage CQ
Number of subjects: 81
Study: 33011207

Group type: EXPERIMENTAL
Intervention: EBRT + HDR-BTb
Number of subjects: 216

Group type: COMPARATOR
Intervention: EBRT alone
Number of subjects: 216
Study: 32967528

Group type: EXPERIMENTAL
Intervention: Seven daily sessions of mindfulness training
Number of subjects: 332

Group type: COMPARATOR
Intervention: One-off mindfulness training session
Number of subjects: 332
Study: 36329182

Group type: EXPERIMENTAL
Intervention: ta‐VNS
Number of subjects: 40

Group type: COMPARATOR
Intervention: sham ta‐VNS
Number of subjects: 40
Study: 32563253

Group type: EXPERIMENTAL
Intervention: Amaranth seed oil (ASO) 20 mL/d
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Rapeseed oil (RSO) 20 mL/d
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (C; untreated)
Number of subjects: 81
Study: 35337314

Group type: EXPERIMENTAL
Intervention: Back exercises (strengthening and stretching exercises)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 44
Study: 33572918

Group type: EXPERIMENTAL
Intervention: Semolina spaghetti
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Wholegrain spaghetti
Number of subjects: 30

Group type: COMPARATOR
Intervention: Wheat-based mee pok noodles
Number of subjects: 30

Group type: COMPARATOR
Intervention: Rice
Number of subjects: 30
Study: 36343646

Group type: EXPERIMENTAL
Intervention: Discontinuation of hypertonic saline
Number of subjects: 594

Group type: COMPARATOR
Intervention: Continuation of hypertonic saline
Number of subjects: 594

Group type: EXPERIMENTAL
Intervention: Discontinuation of dornase alfa
Number of subjects: 594

Group type: COMPARATOR
Intervention: Continuation of dornase alfa
Number of subjects: 594
Study: 34294784

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (SBP) < 130 mmHg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (SBP) 120-129 mmHg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Systolic blood pressure (SBP) ≥ 130 mmHg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diastolic blood pressure (DBP) ≥ 90 mmHg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blood pressure < 130/80 mmHg
Number of subjects: 0
Study: 32081767

Group type: EXPERIMENTAL
Intervention: Educational intervention (breastfeeding support and nutrition education during 10 home visits, birth to 24 months)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Days with caffeine consumption
Number of subjects: 106

Group type: COMPARATOR
Intervention: Days without caffeine consumption
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Caffeine consumption
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Overall dietary intake
Number of subjects: 106
Study: 34008811

Group type: EXPERIMENTAL
Intervention: Walking Training (WT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (30 min of stretching)
Number of subjects: 35
Study: 32729657

Group type: EXPERIMENTAL
Intervention: Derivation cohort (n = 1,931)
Number of subjects: 2588

Group type: EXPERIMENTAL
Intervention: Validation cohort (n = 644)
Number of subjects: 2588
Study: 34100365

Group type: EXPERIMENTAL
Intervention: Gap Balancing (GB) technique
Number of subjects: 99

Group type: COMPARATOR
Intervention: Measured Resection (MR) technique
Number of subjects: 99
Study: 33143647

Group type: EXPERIMENTAL
Intervention: Arthroscopic microfracture with atelocollagen augmentation (group 1, n = 31)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Arthroscopic microfracture alone (group 2, n = 29)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Arthroscopic microfracture with atelocollagen augmentation (group 1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Arthroscopic microfracture alone (group 2)
Number of subjects: 60
Study: 616063504

Group type: EXPERIMENTAL
Intervention: Eribulin
Number of subjects: 29

Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 29
Study: 34981344

Group type: EXPERIMENTAL
Intervention: DEG measure
Number of subjects: 312

Group type: COMPARATOR
Intervention: Patients with NYHA 1-2
Number of subjects: 312

Group type: COMPARATOR
Intervention: Patients without comorbid COPD
Number of subjects: 312
Study: 33960833

Group type: EXPERIMENTAL
Intervention: PRISM intervention group
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 86
Study: 35148512

Group type: EXPERIMENTAL
Intervention: 10-kHz spinal cord stimulation (SCS)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Conventional medical management (CMM)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Crossover arm (after CMM)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Overall study results
Number of subjects: 159
Study: 33020846

Group type: EXPERIMENTAL
Intervention: Connected monitoring
Number of subjects: 94

Group type: COMPARATOR
Intervention: Conventional monitoring
Number of subjects: 94
Study: 32602803

Group type: EXPERIMENTAL
Intervention: Culturally adapted brief intervention delivered in Spanish by promotores in a community setting
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Culturally adapted brief intervention
Number of subjects: 73
Study: 33947827

Group type: EXPERIMENTAL
Intervention: 10-week individual-based multimodal program of task-oriented exercises integrated with cognitive-behavioral therapy
Number of subjects: 150

Group type: COMPARATOR
Intervention: Individual-based general physiotherapy
Number of subjects: 150
Study: 35807780

Group type: EXPERIMENTAL
Intervention: Diet (DI; n = 13)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Exercise and Diet (EX + DI; n = 16)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (CON; n = 16)
Number of subjects: 45
Study: 32838584

Group type: EXPERIMENTAL
Intervention: Vaccine development efforts against sexually transmitted viruses (STVs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Various approaches for improving prophylactic or therapeutic vaccines
Number of subjects: 0
Study: 33141209

Group type: COMPARATOR
Intervention: Usual care (n=326)
Number of subjects: 840

Group type: COMPARATOR
Intervention: Online program only (n=216)
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: Combined intervention (n=298)
Number of subjects: 840
Study: 35360148

Group type: EXPERIMENTAL
Intervention: Diabetes Community Exercise Programme (DCEP) plus usual care
Number of subjects: 165

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 165
Study: 32049228

Group type: EXPERIMENTAL
Intervention: Group Brief Intervention (GBI)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Comparison between EG and CG
Number of subjects: 180
Study: 36495093

Group type: EXPERIMENTAL
Intervention: Aluminum lactate-based antiperspirant
Number of subjects: 50

Group type: COMPARATOR
Intervention: Aluminum chloride-based antiperspirant
Number of subjects: 50
Study: 34021038

Group type: EXPERIMENTAL
Intervention: Combination of rivaroxaban 2.5 mg two times per day and aspirin 100 mg once daily
Number of subjects: 18278

Group type: COMPARATOR
Intervention: Non-study aspirin
Number of subjects: 18278
Study: 32539812

Group type: EXPERIMENTAL
Intervention: cathodal transcranial direct current stimulation (c‐tDCS) combined with virtual reality (VR)
Number of subjects: 40

Group type: COMPARATOR
Intervention: sham stimulation combined with virtual reality (VR)
Number of subjects: 40
Study: 34735312

Group type: EXPERIMENTAL
Intervention: ANODAL tDCS
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: CATHODAL tDCS
Number of subjects: 32

Group type: COMPARATOR
Intervention: SHAM tDCS
Number of subjects: 32
Study: 32183778

Group type: EXPERIMENTAL
Intervention: Laparoscopic transcystic dilation of the cystic duct confluence in CBD exploration (LTD-CBDE)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Laparoscopic common bile duct exploration (LCBDE)
Number of subjects: 68
Study: 34670132

Group type: EXPERIMENTAL
Intervention: Algorithm-guided treatment with escitalopram (AGT-E)
Number of subjects: 987

Group type: EXPERIMENTAL
Intervention: Algorithm-guided treatment with mirtazapine (AGT-M)
Number of subjects: 987

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 987
Study: 32647911

Group type: EXPERIMENTAL
Intervention: FF/UMEC/VI
Number of subjects: 10355
Study: 36122588

Group type: EXPERIMENTAL
Intervention: Individualized homeopathic medicines (IHMs)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34419131

Group type: EXPERIMENTAL
Intervention: Newspaper advertisements
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Clinical referrals
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Web advertisements
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Community-based strategies (advertisement and flyers)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Various recruitment strategies
Number of subjects: 226
Study: 32234000

Group type: EXPERIMENTAL
Intervention: Test formulation of omeprazole enteric-coated tablet 20 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Reference formulation of omeprazole
Number of subjects: 48
Study: 35486415

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no dexmedetomidine)
Number of subjects: 60
Study: 34224994

Group type: EXPERIMENTAL
Intervention: High-dose IFN-β 1a (88 μg on days 1, 3, 6) + lopinavir/ritonavir (400 mg/100 mg twice a day for 10 days)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Low-dose IFN-β 1a (44 μg on days 1, 3, 6) + lopinavir/ritonavir (400 mg/100 mg twice a day for 10 days)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: High-dose IFN-β 1a
Number of subjects: 168

Group type: COMPARATOR
Intervention: Low-dose IFN-β 1a
Number of subjects: 168
Study: 33938926

Group type: EXPERIMENTAL
Intervention: Multifaceted clinical pharmacist intervention
Number of subjects: 459
Study: 36107972

Group type: EXPERIMENTAL
Intervention: ICE (450 g of -2°C ice slurry)
Number of subjects: 12

Group type: COMPARATOR
Intervention: CON (30°C beverage)
Number of subjects: 12

Group type: COMPARATOR
Intervention: WAT (30°C water)
Number of subjects: 12
Study: 33179395

Group type: EXPERIMENTAL
Intervention: Prednisolone plus Tacrolimus (TAC)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Prednisolone plus Cyclosporin A (CsA)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both groups (TAC and CsA)
Number of subjects: 58
Study: 35668002

Group type: EXPERIMENTAL
Intervention: ASA
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 32245746

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg daily
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 34628939

Group type: EXPERIMENTAL
Intervention: HSAT
Number of subjects: 250

Group type: COMPARATOR
Intervention: iPSG
Number of subjects: 250
Study: 33950949

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) plus chemotherapy (Kang Ai injection, herbal decoction, Zhenqifuzheng capsules)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 75
Study: 34214231

Group type: EXPERIMENTAL
Intervention: Fish oil (FO) supplementation
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 33864994

Group type: EXPERIMENTAL
Intervention: Warm salt water foot bath for 20 minutes for a week
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (received a training booklet about chemotherapy-induced fatigue)
Number of subjects: 75
Study: 34482505

Group type: EXPERIMENTAL
Intervention: Hydrogen-rich ultrapure water (HRW) 500 mg of nickel chloride kg‐1 soil for 14 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydrogen-rich ultrapure water (HRW) 200 mg of nickel chloride kg‐1 soil for 14 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydrogen-rich ultrapure water (HRW)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (CW: ultrapure water)
Number of subjects: 0
Study: 34280934

Group type: EXPERIMENTAL
Intervention: Listening to standardized classical music (n = 35)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Listening to music of patients' own choice (n = 34)
Number of subjects: 127

Group type: COMPARATOR
Intervention: No music (control group III, n = 44)
Number of subjects: 127